{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:03:09Z","timestamp":1714129389980},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.canep.2010.05.011","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:41:15Z","timestamp":1277080875000},"page":"644-647","source":"Crossref","is-referenced-by-count":2,"title":["Hospitalization for osteoarthritis and prostate cancer specific mortality among Swedish men with prostate cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Fang","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unnur","family":"Valdimarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorelei","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Spar\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Fall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2010.05.011_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canep.2010.05.011_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.53.082901.104015","article-title":"Chemoprevention of aerodigestive tract cancers","volume":"53","author":"Kim","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.canep.2010.05.011_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2010.05.011_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","article-title":"Breast cancer and NSAID use: a meta-analysis","volume":"84","author":"Khuder","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canep.2010.05.011_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10747","article-title":"Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment","volume":"91","author":"De Marzo","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.canep.2010.05.011_bib6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","article-title":"Prostate carcinogenesis and inflammation: emerging insights","volume":"26","author":"Palapattu","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canep.2010.05.011_bib7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","article-title":"Epidemiology of inflammation and prostate cancer","volume":"171","author":"Platz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.canep.2010.05.011_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","article-title":"Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer","volume":"13","author":"Garcia Rodriguez","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canep.2010.05.011_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/dji173","article-title":"A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence","volume":"97","author":"Jacobs","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canep.2010.05.011_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ijc.11250","article-title":"Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer","volume":"106","author":"Perron","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canep.2010.05.011_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bjc.6601416","article-title":"Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis","volume":"90","author":"Mahmud","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canep.2010.05.011_bib12","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1158\/1078-0432.CCR-05-2067","article-title":"Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy","volume":"12","author":"Pruthi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canep.2010.05.011_bib13","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1200\/JCO.2005.03.7804","article-title":"Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and\/or radiation therapy","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2010.05.011_bib14","first-page":"999","article-title":"Trends in medication use for osteoarthritis treatment","volume":"29","author":"Ausiello","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.canep.2010.05.011_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.canep.2010.05.011_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"key":"10.1016\/j.canep.2010.05.011_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199607253350404","article-title":"The risk of stomach cancer in patients with gastric or duodenal ulcer disease","volume":"335","author":"Hansson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canep.2010.05.011_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1055-9965.EPI-04-0532","article-title":"Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging","volume":"14","author":"Platz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canep.2010.05.011_bib19","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/cncr.23806","article-title":"Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001\u20132002 National Health and Nutrition Examination Survey","volume":"113","author":"Singer","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2010.05.011_bib20","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI114342","article-title":"Damage to the bases in DNA induced by stimulated human neutrophils","volume":"84","author":"Jackson","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.canep.2010.05.011_bib21","first-page":"7415","article-title":"Increased cell division as a cause of human cancer","volume":"50","author":"Preston-Martin","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.canep.2010.05.011_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.3975611","article-title":"Phagocytes as carcinogens: malignant transformation produced by human neutrophils","volume":"227","author":"Weitzman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.canep.2010.05.011_bib23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"Faseb J"},{"key":"10.1016\/j.canep.2010.05.011_bib24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2174\/0929867003374336","article-title":"Role of cyclooxygenases in angiogenesis","volume":"7","author":"Leahy","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.canep.2010.05.011_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.canep.2010.05.011_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1464-410x.2000.00867.x","article-title":"Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment","volume":"86","author":"Madaan","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.canep.2010.05.011_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C","article-title":"Expression of cyclooxygenase-2 in prostate carcinoma","volume":"89","author":"Yoshimura","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2010.05.011_bib28","first-page":"8617","article-title":"Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma","volume":"61","author":"Zha","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canep.2010.05.011_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.06.014","article-title":"Cyclooxygenases in cancer: progress and perspective","volume":"215","author":"Zha","year":"2004","journal-title":"Cancer Lett"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782110001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782110001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:22:02Z","timestamp":1685640122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782110001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1877782110001037"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2010.05.011","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}